DNA damage response (DDR) deficiency and high replication stress are independently of each other in PC, offering therapy strategy for DDR proficient and high replication stress patients with PC with by WEE1 or ATR inhibition based on the drug response in PC PDOs [96]. The gene discussed is ATR; the disease is pachyonychia congenita.